AbstractObjectives:The present study was conducted to examine whether Haedoksamul-tang (HS), a traditional oriental herbal medicine, have beneficail effects on anti-inflammation and dyslipidemia in lipopolysaccharide (LPS)-induced ICR mouse.
Methods:Twenty four 8-week old male ICR mouse were divided into four groups: normal untreated; LPS treatment only; HS 10 mg/kg plus LPS treatment; and HS 30 mg/kg plus LPS treatment. HS was orally administered per day for 2days. Twenty-four hours after LPS injection (10 mg/kg/day, i.p.), all the mice were sacrificed, and serological changes were evaluated. The levels of nuclear factor-κB (NF-κB), sterol regulatory element-binding transcription protein 1 (SREBP-1) activity and cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), tumor necrosis factor a (TNF-a), monocyte chemotactic protein 1 (MCP-1), acetyl-CoA carboxylase a (ACCa) expression were analyzed in Western blot analysis.
Results:HS inhibited oxidative stress in the liver of LPS-induced ICR mice. The LPS-induced ICR mice exhibited the increase of NF-κB activity and COX-2, iNOS, TNF-a, MCP-1 expressions in the liver, while HS treatment significantly inhibited them. Moreover, The administration of HS significantly decreased the elevated serum triglyceride and down-regulated the levels of SREBP-1, ACCa in the liver of LPS-induced ICR mice.
참고문헌2.. Feng X, Zhang Y, Xu R, Xie X, Tao L, Gao H, et al. Lipopolysaccharide up-regulates the expression of Fcalpha/mu receptor and promotes the binding of oxidized low-density lipoprotein and its IgM antibody comples to activated human macrophages. Atherosclerosis. 2010; 208:396–405.
![]() 3.. Wiesner P, Choi SH, Almazan F, Benner C, Huang W, Diehl CJ, et al. Low doses of lipopolysaccharide and minimally oxidized low-density lipoprotein cooperatively activate macrophages via nuclear factor kappa B and activator protein-1: possible mechanism for acceleration of atherosclerosis by subclinical endotoxemia. Circ Res. 2010; 107:56–65.
![]() 4.. Maitra U, Li L. Molecular mechanisms responsible for the ruduced expression of cholesterol transporters from macrophages by low-dose endotoxin. Arterioscler Thromb Vasc Biol. 2013; 33:24–33.
![]() 5.. Vikatmaa P, Lajunen T, Ikonen TS, Pussinen PJ, Leinonen M, Saikku P, et al. Chlamydial lipopolysaccharide (cLPS) is present in atherosclerotic and aneurysmal arterial wall--cLPS levels depend on disease manifestation. Cardiovasc Pathol. 2010; 19:1. 48–54.
![]() 6.. Jean L, Bret D, Chistophe C. Systemic capsaicin pretreatment fails to bolck the decrease in food-motivated behavior induced by lipopolysaccharide and interleukin-1ß. Brain Research Bul. 1997; 42:443–9.
![]() 7.. Sharifov OF, Nawar G, Ternovov W, Mishra VK, Litovsky SH, Palqunachare MN, et al. Cationic peptide mR18L with lipid lowering properties inhibits LPS-induced systemic and liver inflammation in rats. Biochem Biophys Res Commun. 2013; 436:4. 705–10.
![]() 8.. Kim ID, Kang KS, Kwon RH, Yang JO, Lee JS, Ha BJ. The effect of Rubus coreanum Miquel against lipopolysaccharide-induced oxidative stress and lipid metaobolism. J. Fd Hyg. Safety. 2007; 22:3. 213–7.
9.. Ju JH. Dan-gye-sim-beop-bu-yeo. Seoul: Daesung Publishing Co. Ltd;1982. p. 714
10.. Lee SI. Cheon-jin-cheo-bang-hea-sheol. Seoul: Sheong-bo-sa;1995. p. 289–91.
11.. Kim ES. A experimental study of Hwangryeonheadock-Tang and Onchung-Eum on hyperlipidemia & hypertension. J. of Korean Medicine. 1999; 20:1. 185–96.
12.. Kim YH, Jo HB. Anti-inflammatory effects of Haedoksamul-tang in RAW 264.7 cells. J. of Oriental Obstetrics & Gynecology. 2008; 21:2. 166–83.
13.. Beom HB. Effects of Onchungeum and Gamionchungeum on the antiallergic response and blood coagulation. J. of Kyung Hee University. 1990; 6:4. 490–9.
14.. Jeon YG. Effects of Haedoksamul-tang on Trimelliticanhydride-induced contact hypersensitivity in a mouse model. 2010; 1–41.
15.. Seo M, Jeon BH, Woo WH, Jeong WY. Effect of Onchengyeum on the damaged liver cell by carbon tetrachloride in rats. Korean J. Oriental Physiology & Pathology. 1989; 11:2. 27–36.
16.. Im HJ, Hwang CY, Gang HC, Kim NG, Gwon IH. Inhibitory effects of Onchumgeum on cytokine production from phytohaemagglutin-stimulated peripheral blood mononuclear cells of behcets patients. Korean J. Oriental Physiology & Pathology. 2002; 16:4. 768–73.
17.. Zhu GF, Guo HJ, Huang Y, Wu CT, Zhang XF. Eriodictyol, a plant flavonoid, attenuates LPS-induced acute lung injury through its antioxidative and anti-inflammatory activity. Exp Ther Med. 2015; 10:6. 2259–66.
![]() 18.. Heo J. Dong-ui-bo-gam. Seoul: Bubin Publishing Co. Ltd;2007. 416:p. 455
19.. Rush GF, Gorski JR, Ripple MG, Sowinski J, Bugelski P. Organic hydroperoxide -induced lipid peroxidation and cell death in isolated hepatocytes. Toxicol Appl Pharmacol. 1985; 78:473–83.
![]() 20.. Izeboud CA, Hoebe KH, Grootendorst AF, Nijmeijer SM, van Miert AS, Witkamp RF, et al. Endotoxin-induced liver damage in rats is minimized by beta 2-adrenoceptor stimulation. Inflamm Res. 2004; 53:93–9.
![]() 21.. Munford RS. Severe sepsis and septic sock: the role of gram-negative bacteremia. Annu Rev Pathol. 2006; 1:467–96.
![]() 22.. Kleemann R, Verschuren L, van Erk M, Nikolsky Y, Verheij ER, Smilde AK, et al. Atherosclerosis and liver inflammation induced by increased dietary cholesterol intake: a combined transcriptomics and metabolomics analysis. Genome Biol. 2007; 8:R200
![]() 23.. Xu X, Hu J, McGrath BC, Cavener DR. GCN2 in the brain programs PPARγ2 and triglyceride storage in the liver during perinatal development in response to maternal dietary fat. PLos One. 2013; 8:10. e75917
![]() 24.. Liu RH, Hotchkiss JH. Potential genotoxicity of chronically elevated nitirc oxide: a review. Mutat. Res. 1996; 339:73–89.
![]() 25.. Collins T, Cybulsky MI. NF-kappaB: pivotal mediator or innocent bystander in atherogenesis. J Clin Invest. 2001; 107:255–64.
![]() 26.. Thuberg BL, Collins T. The nuclear factor-B/inhibitor of B autoregulatory system and atherosclerosis. Curr Opin Lipidol. 1998; 9:387–96.
![]() 27.. Wang QS, Xiang Y, Cui YL, Lin KM, Zhang XF. Dietary blue pigments derived from Genipin, attenuate inflammation by inhibiting LPS-Induced iNOS and COX-2 expression via the NF-κB inactivation. PLos One. 2012; 7:3. 1–11.
![]() 28.. Kwon HJ, Sung BK, Kim JW, Lee JH, Kim ND, Yoo MA, et al. The effect of lipopolysaccharide on enhanced inflammatory process with age: modulation of NF-κB. J. Amer. Aging Assoc. 2001; 24:163–72.
![]() 29.. Napoli C, de Nigris F, Williams-Ignarro S, Pignalosa O, Sica V, Ignarro LJ. Nitric oxide and atherosclerosis: an update. Nitric Oxide. 2006; 15:265–79.
![]() 30.. Baldwin AS. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol. 1996; 14:649–83.
![]() 31.. DeGraba TJ. Expression of inflammatory mediators and adhesion molecules in human atherosclerotic plaque. Neurology. 1997; 49:Supple 4. S15–9.
![]() 32.. Fassbender K, Rossol S, Kammer T, Daffertshofer M, Wirth S, Dollman M, et al. Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. J Neurol Sci. 1994; 122:2. 135–9.
![]() 33.. Adams DH, Lioyd AF. Chemokines: leukocyte recruitment and activation cytokines. Lancet. 1997; 349:490–5.
![]() 34.. Brown MS, Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell. 1997; 89:331–40.
![]() 35.. Weber LW, Boll M, Stampfl A. Maintaining cholesterol homeostasis: sterol regulatory element-binding proteins. World J Gastroenterol. 2004; 10:21. 3081–7.
![]() 36.. Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest. 2002; 109:1125–31.
![]() 37.. Foufelle F, Ferre P. New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c. Biochem J. 2002; 366:377–91.
![]() 38.. Ferre P, Foretz M, Azzout-Marniche D, Becard D, Foufelle F. Sterol-regulatory-element-binding protein 1c mediates insulin action on hepatic gene expression. Biochemical Society Transactions. 2001; 29:4. 547–52.
![]() 39.. Horton JD. Sterol regulatory element-binding proteins: transcriptional activators of lipid synthesis. Biochemical Society Transactions. 2001; 30:6. 1091–5.
![]() |
|